Literature DB >> 25747812

Seborrheic keratosis with bowenoid transformation: the immunohistochemical features and its association with human papillomavirus infection.

Yu-Hung Wu1, Pa-Fan Hsiao, Chi-Kuan Chen.   

Abstract

The bowenoid transformation of seborrheic keratosis (SK) has rarely been reported. The purpose of this study is to identify their diagnostic immunohistochemical features and association with human papillomavirus (HPV) infection. Skin biopsy specimens of the phenomenon were retrieved from 2001 to 2010. Benign SK, Bowen disease, bowenoid papulosis, and squamous cell carcinoma were included as controls. All specimens were stained for hematoxylin and eosin, Ki-67, p21, p16, p53, and cyclin D1. Polymerase chain reaction-amplified HPV DNA was analyzed. Seventeen cases of SK with bowenoid transformation were identified. The immunohistochemical pattern of bowenoid transformation was similar to that of Bowen disease and bowenoid papulosis. The malignant cells exhibited increased expressions of p16, p21, and ki-67 and a decreased expression of cyclin D1 (P < 0.01). HPV DNA was detected in 5 cases of bowenoid transformation. In conclusion, a portion of the cases of SK with bowenoid transformation were associated with HPV infection. Selective immunohistochemical stains were helpful in the diagnosis of malignant change in these cases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25747812     DOI: 10.1097/DAD.0000000000000285

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

Review 1.  Seborrheic Keratoses - The Most Common Benign Skin Tumor of Humans. Clinical presentation and an update on pathogenesis and treatment options.

Authors:  Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2018-11-23

2.  Transformation of Seborrheic Keratosis into Bowenoid Actinic Keratosis via Three Steps of Histological Change in a Patient with Rheumatoid Arthritis Treated with Multiple Immunosuppressants.

Authors:  Masahiro Oka; Yuki Yamamoto; Miki Fujii
Journal:  Case Rep Dermatol       Date:  2020-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.